Hey Doc so I only mentioned Avita as their revenue growth has slumped- whereas ARX and PNV revenue growth is still pretty rapid. You have made an assumption i haven't research Avita, but I have and I have commented on Avita before being a complementary tech, not a competitor, but anyway- you don't seem to read peoples posts well and go down the wrong tangents- you should try reading peoples posts- we all have something to offer. Not just the doctors.
Their Myriad product it now seems, alongside Ovatex where they are focusing- comments from ARX investors in Myriad is the newer improved product (they have 2 Myriad products. Their growth of accounts they are selling to for Myraid increased 350% from last year (thats impressive new account signings for Myriad)
Their partnership with TelaBio, who is growing 50-55% and is a similar revenue size as PNV is a big plus for Aroa I think- as thats an entire salesforce focused just on Ovatex hernia and breast products.
So effectively then, Aroa has 220 staff + the staff of Tela Bio selling its Ovatex- so it might have 250-270 staff focusing on ARX products vs PNV 150 staff.
What I do like about PNV, is the revenue per employee- if you compare PNV to ARX 220 staff, PNV is able to achieve 293 K per person vs ARX 163 K per person. this suggests that perhaps ARX has too many people working for it and will burn through cash very quickly, whereas PNV if we get cash flow positive/ break even is now a sustainable business, without need for ongoing CRs (whereas ARX hasn't reached that point , still diluting through CR)
Its curious that PNVs one product, BTM Novosorb is able to achieve 20% more sales than ARXs combined all products- and PNV hasn't been around as long.
- Forums
- ASX - By Stock
- PNV
- coming down to Aroa and Polynovo; Avita seems out of the race for bow
coming down to Aroa and Polynovo; Avita seems out of the race for bow, page-36
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B |
Open | High | Low | Value | Volume |
$2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 35541 | $2.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.46 | 2681 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8773 | 2.450 |
3 | 6522 | 2.430 |
1 | 2681 | 2.420 |
3 | 6302 | 2.410 |
3 | 5925 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.460 | 2681 | 1 |
2.470 | 2681 | 1 |
2.480 | 23333 | 3 |
2.490 | 12681 | 2 |
2.500 | 92672 | 4 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online